SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company
NKTR 56.70+5.1%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (106)9/8/2006 5:55:12 PM
From: Arthur Radley  Read Replies (2) of 507
 
Tuck,
As stated...I wish you luck with NKTR, but the trading trend on this puppy isn't that positive.
1) Stock is actually trading lower than when it got FDA approval.
2) NKTR/PFE hyped that they were building inventory in their Indiana warehouse for immediate launch on getting FDA approval. Now nearly 9 months after approval.....silence!!!
3) NKTR reported that the product was launched in Germany in May, 2006. Stock trading gives me the impression that sales must not be that great in Germany...as surely 4 months into marketing the product MUST give some indication of how the product is being received. I think it safe to assume that Wall Street has access to the German launch results, by now!

Good luck...a put position might be in order because PFE is having major presentation next week....if long, I would be listening to this presentation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext